93 related articles for article (PubMed ID: 11365864)
1. Amprenavir (Agenerase) now available in expanded access.
AIDS Treat News; 1998 Oct; (No 304):5. PubMed ID: 11365864
[TBL] [Abstract][Full Text] [Related]
2. Amprenavir, new protease inhibitor, approved.
James JS
AIDS Treat News; 1999 May; (No 318):1-3. PubMed ID: 11366454
[TBL] [Abstract][Full Text] [Related]
3. Experimental drug available.
Vazquez E
Posit Aware; 1998; 9(6):17. PubMed ID: 11366472
[TBL] [Abstract][Full Text] [Related]
4. Amprenavir (Agenerase).
Simmons P
Res Initiat Treat Action; 1999 Jul; 5(3):7-10. PubMed ID: 11366726
[TBL] [Abstract][Full Text] [Related]
5. Amprenavir: a new protease inhibitor nears approval.
Highleyman L
BETA; 1999 Jan; 12(1):8-9. PubMed ID: 11367244
[TBL] [Abstract][Full Text] [Related]
6. Expanded access program begins.
Highleyman L
BETA; 1998 Oct; ():3. PubMed ID: 11365989
[TBL] [Abstract][Full Text] [Related]
7. Drug approval.
AIDS Policy Law; 1999 Apr; 14(8):12. PubMed ID: 11366532
[TBL] [Abstract][Full Text] [Related]
8. Glaxo Wellcome's two new drugs.
Res Initiat Treat Action; 1998 Dec; 4(7):14. PubMed ID: 11366081
[TBL] [Abstract][Full Text] [Related]
9. Study: new drug doesn't display cross-resistance.
AIDS Alert; 1999 Jul; 14(7):77. PubMed ID: 11366418
[TBL] [Abstract][Full Text] [Related]
10. Trials for protease failure.
Posit Aware; 1998; 9(5):16-7. PubMed ID: 11365884
[TBL] [Abstract][Full Text] [Related]
11. Amprenavir (Agenerase) receives FDA approval. Food and Drug Administration.
Highleyman L
BETA; 1999 Apr; 12(2):3. PubMed ID: 11366693
[TBL] [Abstract][Full Text] [Related]
12. New protease inhibitor.
Vazquez E
Posit Aware; 1999; 10(3):24. PubMed ID: 11366764
[TBL] [Abstract][Full Text] [Related]
13. Amprenavir approved.
STEP Perspect; 1999; 99(2):8. PubMed ID: 11366753
[TBL] [Abstract][Full Text] [Related]
14. Amprenavir: a new HIV protease inhibitor.
Med Lett Drugs Ther; 1999 Jul; 41(1057):64-6. PubMed ID: 10436772
[No Abstract] [Full Text] [Related]
15. Patients sought for ACTU studies that will help answer questions about drugs.
Fac Notes (New Orleans La); 1998; 10(6):6. PubMed ID: 11366145
[TBL] [Abstract][Full Text] [Related]
16. Amprenavir (Agenerase).
Res Initiat Treat Action; 2000 Mar; 6(1):32-3. PubMed ID: 11708186
[No Abstract] [Full Text] [Related]
17. Access to efavirenz and amprenavir.
Gilden D
GMHC Treat Issues; 1998 Oct; 12(10):12. PubMed ID: 11365902
[TBL] [Abstract][Full Text] [Related]
18. Updated data on amprenavir.
AIDS Patient Care STDS; 1999 May; 13(5):307. PubMed ID: 10356811
[No Abstract] [Full Text] [Related]
19. New expanded access drugs for use in combination therapy.
Newsline People AIDS Coalit N Y; 1998 Dec; ():22-3. PubMed ID: 11367085
[TBL] [Abstract][Full Text] [Related]
20. Expanded access to experimental drugs: activists seek more open programs.
Grinberg L
AIDS Treat News; 1997 Nov; (No 282):6-7. PubMed ID: 11364904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
